Bausch plus Lomb Corporation (BLCO)

Form 4 - Statement of changes in beneficial ownership of securities

Form SD - Specialized disclosure report

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

Blink Triple Care Preservative Free eye drops are made with the same clinically proven formula as Blink Triple Care and provide up to 10 hours...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today...

Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today...

Form 8-K - Current report

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

PreserVision AREDS3™ eye vitamins combine clinically proven AREDS2 nutrients recommended by the National Eye Institute (NEI) to help reduce the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

Increased cutting speed of 25,000 cuts per minute1 is designed to minimize retinal traction,2 increase vitreous flow1 and reduce infusion...

Bausch + Lomb Announces Second R&D “Teach-in” Webinar

Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care Bausch + Lomb...

Form 4 - Statement of changes in beneficial ownership of securities